sore
throat
common
present
primari
care
intern
includ
thailand
approxim
throat
infect
caus
virus
commonli
influenza
parainfluenza
coronaviru
rhinoviru
adenoviru
enterovirus
antibiot
ineffect
infect
bacteri
pathogen
identifi
case
group
streptococcu
ga
studi
thai
adult
present
ambulatori
care
acut
upper
respiratori
tract
infect
urti
found
presenc
follow
bacteria
ga
streptococcu
bh
klebsiella
pneumonia
streptococcu
pneumonia
coagulaseneg
staphylococcu
staphylococcu
aureu
hemophilu
influenza
enterobact
spp
proteu
chiang
rai
northern
thailand
pharyng
tonsil
make
respiratori
tract
infect
present
govern
primari
care
nation
guidelin
recommend
use
centor
score
determin
need
antibiot
requir
penicillin
v
amoxicillin
recommend
macrolid
case
penicillin
antibiot
typic
amoxicillin
prescrib
case
antibiot
resist
import
problem
develop
develop
world
thailand
estim
death
thought
caus
multidrugresist
hospitalacquir
infect
given
antibiot
use
even
narrowspectrum
agent
drive
antimicrobi
resist
amr
intervent
achiev
safe
reduct
antibiot
use
need
cochran
review
compar
antibiot
treatment
placebo
sore
throat
found
reduct
symptom
sever
howev
averag
symptom
durat
reduc
reduc
risk
complic
often
use
justif
antibiot
treatment
larg
cohort
studi
albeit
highincom
set
uk
found
risk
suppur
complic
otiti
media
sinus
quinsi
cellul
around
without
antibiot
treatment
case
acut
rheumat
fever
poststreptococc
nonetheless
find
may
applic
low
middleincom
countri
lmic
preval
rheumat
heart
diseas
higher
global
burden
diseas
studi
found
high
burden
rheumat
heart
diseas
oceania
south
asia
central
subsaharan
africa
burden
lower
southeast
asia
thailand
consid
nonendem
rheumat
heart
current
guidelin
recommend
antibiot
pharyng
caus
ga
narrowspectrum
penicillin
concern
grow
increas
level
ga
resist
macrolid
import
identifi
like
benefit
antibiot
use
reduc
unnecessari
antibiot
use
limit
amr
achiev
varieti
method
use
limit
success
best
current
refer
standard
diagnosi
ga
cultur
although
length
time
requir
gener
result
limit
use
affect
manag
decis
primari
care
altern
use
primari
care
includ
rapid
antigen
test
clinic
score
centor
feverpain
biomark
inflamm
creactiv
protein
crp
studi
assess
crp
perform
identifi
presenc
ga
patient
present
primari
care
sore
throat
pharyng
produc
mix
result
studi
find
crp
wherea
other
rapid
molecular
test
ga
also
develop
prove
valuabl
set
northern
australia
high
burden
ga
acut
poststreptococc
glomerulonephr
acut
rheumat
fever
main
object
evalu
perform
crp
identifi
presenc
ga
among
peopl
consult
sore
throat
fever
chiang
rai
governmentrun
primari
care
unit
secondari
object
estim
preval
ga
key
pathogen
studi
antibiot
suscept
ga
isol
compar
perform
crp
centor
feverpain
clinic
score
throat
swab
collect
place
ami
transport
medium
charcoal
store
process
shoklo
malaria
research
unit
smru
laboratori
tak
provinc
thailand
sampl
plate
onto
blood
agar
incub
hour
presenc
bh
confirm
gram
stain
catalas
lancefield
group
ga
isol
test
antimicrobi
suscept
disk
diffus
accord
clinic
laboratori
standard
institut
smru
laboratori
accredit
particip
extern
qualiti
assur
eqa
includ
eqa
program
depart
medic
scienc
ministri
public
health
thailand
bacteri
identif
antimicrobi
suscept
test
patient
within
control
group
also
nasopharyng
swab
taken
test
use
array
card
tac
life
technologiestm
waltham
assay
screen
pathogen
singl
run
multiplex
revers
transcriptas
realtim
polymeras
chain
reaction
see
supplementari
materi
articl
fulfil
microbiolog
investig
criteria
report
object
micro
framework
checklist
requir
standard
report
clinic
microbiolog
descript
statist
use
summar
demograph
data
use
count
percentag
categor
data
median
iqr
continu
variabl
without
normal
distribut
ranksum
use
compar
crp
valu
posit
throat
swab
neg
bh
conting
tabl
use
calcul
sensit
specif
crp
detect
ga
bh
isol
wilson
method
use
calcul
ci
estim
fisher
exact
test
use
estim
correl
crp
valu
mgl
centor
score
feverpain
score
ga
detect
compar
bh
isol
low
number
per
categori
pvalu
consid
statist
signific
analys
conduct
use
stata
colleg
station
tx
analys
conduct
full
dataset
without
imput
miss
data
betahemolyt
streptococci
isol
throat
swab
ga
four
group
b
four
group
c
one
group
f
group
g
one
nongroup
ga
isol
sensit
ceftriaxon
penicillin
g
resist
erythromycin
clindamycin
chloramphenicol
isol
singl
isol
resist
three
antibiot
intermedi
sensit
erythromycin
found
chloramphenicol
differ
isol
see
tabl
clinic
featur
patient
ga
shown
tabl
patient
ga
eight
abnorm
throat
examin
four
pharyng
four
common
cold
three
tonsil
four
prescrib
antibiot
index
consult
one
addit
patient
control
group
high
crp
prescrib
antibiot
return
visit
day
none
patient
sourc
antibiot
elsewher
week
followup
patient
report
symptom
resolut
day
case
one
patient
persist
cough
symptom
fever
sore
throat
runni
nose
resolv
median
crp
valu
swab
result
shown
tabl
two
miss
crp
valu
enrol
main
rct
median
crp
level
signficantli
higher
patient
ga
bh
isol
p
higher
bh
isol
p
creactiv
protein
mgl
sensit
ci
specif
ci
detect
ga
compar
bh
isol
signific
statist
relationship
crp
valu
mgl
p
centor
score
p
feverpain
score
p
diagnosi
ga
compar
bh
isol
group
streptococcu
found
patient
present
sore
throat
histori
fever
lower
estim
metaanalysi
patient
present
primari
care
emerg
depart
present
symptom
pharyng
urti
found
ga
found
higher
preval
highincom
countri
lmic
find
similar
studi
thailand
found
ga
patient
present
studi
influenzalik
ill
lao
pdr
report
antibiot
resist
level
vari
across
globe
time
studi
found
isol
sensit
penicillin
ceftriaxon
despit
report
ceftriaxon
resist
emerg
iran
need
explor
confirm
histor
ga
fulli
suscept
penicillin
erythromycin
resist
found
ga
isol
import
antibiot
treatment
pharyng
penicillin
allergi
nation
amr
surveil
center
report
lower
level
erythromycin
resist
isol
hospit
across
thailand
resist
level
studi
lower
report
india
iran
south
korea
similar
greec
higher
unit
state
report
macrolid
resist
caus
concern
limit
use
empir
treatment
sore
crossresist
macrolid
lincosamid
eg
clindamycin
occur
erm
clindamycin
erythromycin
resist
found
isol
higher
report
clindamycin
resist
unit
state
greec
thai
nation
data
india
iran
south
korea
resist
level
chloramphenicol
much
higher
report
thai
nation
result
limit
number
ga
isol
indic
narrowspectrum
penicillin
remain
mainstay
treatment
ga
pharyng
thailand
thu
concern
none
patient
sore
throat
fever
receiv
antibiot
receiv
penicillin
almost
receiv
amoxicillin
find
limit
studi
also
seen
primari
care
unit
district
chiang
rai
previou
review
antibiot
use
primari
care
consist
thai
antibiot
guidelin
give
option
treatment
penicillin
v
amoxicillin
ga
given
current
concern
develop
amr
larg
fuel
overus
possibl
intuit
use
narrowspectrum
ie
penicillin
v
rather
broadspectrum
ie
amoxicillin
antibiot
caution
also
requir
use
erythromycin
surveil
amr
conduct
use
updat
treatment
guidelin
diagnos
ga
decid
whether
antibiot
need
remain
challeng
best
approach
vari
depend
set
avail
health
care
diagnost
well
preval
ga
infect
carriag
complic
rheumat
heart
thailand
comprehens
primari
healthcar
system
exist
popul
access
univers
health
coverag
antibiot
avail
pharmaci
diagnost
test
ga
routin
avail
primari
care
preval
ga
rel
low
studi
rheumat
heart
diseas
uncommon
cohort
patient
prescrib
antibiot
despit
third
ga
case
prescrib
antibiot
index
consult
one
report
symptom
resolut
day
depend
guidanc
follow
prescript
rate
would
vari
greatli
within
cohort
patient
use
isol
ga
throat
swab
indic
antibiot
treatment
accord
current
guidanc
case
would
requir
antibiot
would
increas
group
c
g
streptococci
also
treat
crp
threshold
mgl
use
patient
would
prescrib
antibiot
miss
patient
presenc
ga
may
seem
like
low
crp
cutoff
clinic
medium
crp
level
present
sore
throat
fever
mgl
primari
care
diagnost
test
mostli
use
rule
rather
rule
seriou
infect
increas
crp
cutoff
would
reduc
sensit
centor
score
patient
would
requir
antibiot
compar
patient
feverpain
score
potenti
prescrib
antibiot
feverpain
score
intervent
would
reduc
antibiot
prescript
compar
routin
care
patient
diagnos
tonsil
pharyng
set
prescrib
antibiot
almost
exclus
amoxicillin
strategi
use
throat
swab
patient
impract
thai
primari
care
set
clinic
score
feasibl
although
whether
reliabl
identifi
ga
infect
question
indic
data
previou
current
high
prescript
rate
routin
care
also
indic
healthcar
worker
limit
confid
withhold
antibiot
base
clinic
score
pointofcar
crp
test
give
result
within
minut
make
use
primari
care
feasibl
option
howev
although
patient
ga
significantli
higher
median
crp
level
associ
crp
mgl
centor
score
feverpain
score
ga
detect
poor
withhold
antibiot
patient
crp
mgl
would
miss
patient
posit
throat
swab
ga
could
explain
imperfect
sensit
crp
could
also
due
ga
carriag
rather
activ
infect
patient
centor
score
feverpain
score
neither
antibiot
prescrib
index
consult
yet
symptom
resolut
day
specif
crp
test
identifi
pharyng
caus
ga
poor
crp
rais
infect
inflammatori
major
limit
studi
small
number
ga
isol
retrospect
calcul
centor
feverpain
clinic
score
cervic
lymph
node
examin
record
limit
possibl
centor
score
rather
could
lead
underestim
centor
score
may
affect
abil
score
identifi
pharyng
caus
ga
feverpain
score
may
also
imprecis
presenc
tonsillar
exud
inflam
tonsil
collect
descript
abnorm
throat
examin
howev
may
overestim
number
patient
fever
last
hour
patient
histori
fever
last
one
day
anoth
limit
throat
swab
healthi
control
patient
determin
carriag
level
ga
gener
popul
metaanalysi
estim
ga
carriag
level
age
high
lowincom
set
children
adult
also
possibl
throat
swab
cultur
may
identifi
ga
case
studi
nest
within
larger
clinic
trial
pointofcar
crp
test
guid
antibiot
use
febril
ill
final
rate
antibiot
prescrib
studi
rel
low
may
influenc
observ
effect
given
limit
studi
valid
indic
antibiot
prescript
ga
pharyng
thailand
requir
combin
clinic
score
crp
test
may
offer
practic
effect
approach
conclus
less
patient
present
primari
care
thailand
sore
throat
histori
fever
ga
detect
penicillin
appropri
empir
antibiot
need
treatment
surveil
macrolid
resist
requir
suscept
test
may
warrant
penicillin
allergi
identifi
patient
pharyng
requir
antibiot
prescript
remain
challeng
requir
data
larger
studi
howev
despit
small
sampl
size
crp
level
higher
patient
ga
isol
without
bh
isol
reli
crp
test
alon
would
result
high
level
antibiot
prescript
sore
throat
set
includ
chiang
rai
would
still
repres
import
reduct
antibiot
prescript
compar
routin
care
target
crp
test
use
clinic
score
like
costeffect
approach
rule
ga
infect
